Patents for C12P 21 - Preparation of peptides or proteins (112,499)
07/2013
07/17/2013CN101605810B Chimeric human sweet-umami and umami-sweet taste receptors
07/17/2013CN101423859B Method for improving protease use efficiency
07/17/2013CN101397564B Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors
07/17/2013CN101076730B Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
07/16/2013US8487083 Monoclonal antibodies capable of simultaneously binding domains II and IIIc of type 1 fibroblast growth factor receptor
07/16/2013US8487081 Antibodies specific for human hepcidin
07/16/2013US8486893 Treatment of conditions involving demyelination
07/16/2013US8486681 Alpha-amylase variant with altered properties
07/16/2013US8486678 Pharmaceutical compositions for the treatment of virus infection
07/16/2013US8486667 EGVII endoglucanase and nucleic acids encoding the same
07/16/2013US8486663 Compositions and methods for generating antibodies
07/16/2013US8486662 DNA encoding antibody molecules having specificity for human IL-6
07/16/2013US8486660 Methods and compositions for concentrating secreted recombinant protein
07/16/2013US8486659 Isoprenoid compounds
07/16/2013US8486657 Anti-preproprotein and anti-preprotein antibodies as immunohistochemical markers
07/16/2013US8486646 Methods of using a G protein-coupled receptor to identify peptide YY (PYY) secretagogues
07/16/2013US8486624 Lafora's disease gene
07/16/2013US8486468 Porphyrin containing lactic acid bacterial cells and use thereof
07/16/2013US8486401 Monoclonal antibodies binding to TrkA and acting as NGF-antagonist molecules and their use for treating pain induced by NGF
07/16/2013US8486394 Generation and Profiling of fully human hucal gold-derived therapeutic antibodies specific for human CD38
07/16/2013CA2498213C Induction of gene expression using a high concentration sugar mixture
07/16/2013CA2460639C Engineered templates and their use in single primer amplification
07/16/2013CA2350334C New family of mammalian potassium channels, their cloning and their use, especially for the screening of drugs
07/11/2013WO2013103659A1 Stabilizing rna by incorporating chain-terminating nucleosides at the 3'-terminus
07/11/2013WO2013020087A3 Nucleic acid compositions, methods and kits for rapid pairing of affinity agents
07/11/2013WO2013019946A3 Protease-deficient bacillus anthracis
07/11/2013WO2011163012A3 Amide based glucagon superfamily peptide prodrugs
07/11/2013WO2011050008A9 Combination therapy comprising administration of an amylinomimetic and a pyy peptidomimetic for effecting weight loss and for treating obesity and related metabolic conditions and disorders
07/11/2013US20130177942 Methods of Improving the Introduction of DNA into Bacterial Cells
07/11/2013US20130177940 C-terminal modification of polypeptides
07/11/2013US20130177919 Protein production
07/11/2013US20130177545 Methods for introducing mannose 6 phosphate and other oligosaccharides onto glycoproteins and applications thereof
07/11/2013US20130177538 Human lysosomal proteins from plant cell culture
07/10/2013EP2612922A1 Eggshell membrane solubilization method using enzymes
07/10/2013EP2612921A1 Process for production of novel degalactosylated gc globulin
07/10/2013EP2612903A1 Alga in which production of photosynthetic products is improved, and use for said alga
07/10/2013EP2612866A2 Polypeptide associated with the synthesis of 1-deoxynojirimycin, and a use therefor
07/10/2013EP2612675A1 Treatment of development-related disorders
07/10/2013EP2611927A1 Novel single chemical entities and methods for delivery of oligonucleotides
07/10/2013EP2611926A1 Preparation and purification of subnut vaccine for neisseria meningitidis (nm) group b isolates
07/10/2013EP2611417A2 Method for producing a tetranectin-apolipoprotein a-1 particle, the lipid particle obtained therewith and its use
07/10/2013CN1970571B G-csf analog compositions and methods
07/10/2013CN1541109B Inhibitors of HER3 activity
07/10/2013CN103201291A Anti single-strand type-iv collagen polypeptide antibody, and pharmaceutical, or agent for diagnosing, preventing or treating tumours, containing same
07/10/2013CN103201285A Modified relaxin polypeptides and their uses
07/10/2013CN103200963A Dual variable domain immunoglobulins and uses thereof
07/10/2013CN103194519A Method for preparing antioxidative peptide through proteolysis on pea protein and application thereof
07/10/2013CN103194518A Preparation method of fish collagen peptides with narrow molecular weight ranges
07/10/2013CN103194517A Chickpea short-peptide mixture and preparation method thereof
07/10/2013CN103194516A Preparation method of cordyceps militaris polypeptide
07/10/2013CN103194515A Method for preparing silkworm pupa protein ACE (angiotensin-I converting enzyme) inhibitory peptide by continuous enzyme membrane reaction, and product and application thereof
07/10/2013CN103194514A Method for preparing sugar grass seed protein ACE (Angiotensin Converting Enzyme) inhibitory peptide through binary-enzyme step hydrolysis, and product and application of sugar grass seed protein ACE inhibitory peptide
07/10/2013CN103194513A Method for efficiently extracting spleen aminopeptide
07/10/2013CN103194512A Soybean peptide for promoting lactobacillus proliferation and improving lactobacillus survivability as well as preparation method and application thereof
07/10/2013CN103194482A Plasmid and recombinant bacterium for expression of human serum albumin and application thereof
07/10/2013CN103194481A Plasmid and recombinant bacterium for expression of human serum albumin and application thereof
07/10/2013CN103194461A Metarrhizium anisopliae destruxins (dtx) synthesis related gene and applications thereof
07/10/2013CN103194442A Novel polypeptide and hydrolyzed antibacterial peptide and preparation method thereof
07/10/2013CN103194411A Bacillus subtilis and application of bacillus subtilis to production of antimicrobial peptide
07/10/2013CN103193885A Anti-EPHRINB2 antiboies and methods using same
07/10/2013CN102115774B Method for preparing plant polypeptide by enzyme process
07/10/2013CN101891816B Humanized monoclonal antibody IgG Fab fragment of dermatophagoides farinae 2 allergoid specificity as well as preparation method and application thereof
07/10/2013CN101881770B Method for preparing porcine circovirus type 2 colloidal gold antibody fast test strip
07/10/2013CN101643511B Fusion protein for inhibiting telomerase activity, preparation and application thereof
07/10/2013CN101360831B Recombinant N-glycosylated proteins from procaryotic cells
07/09/2013US8481706 Method for overproducing specific recombinant protein with P. cinnabarinus monokaryotic strains
07/09/2013US8481704 Nucleic acid molecule encoding human GM-CSF antigen binding proteins
07/09/2013US8481685 Modified DNA polymerases
07/09/2013US8481683 Human antibodies that bind CD22 and uses thereof
07/09/2013US8481677 Protein concentrate from starch containing grains: composition, method of making, and uses thereof
07/09/2013US8481320 Methods for increasing homologous recombination of a nucleic acid sequence
07/09/2013US8481314 Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized LDL receptor-1 (LOX-1)
07/09/2013US8481310 Tag peptide having a protease recognition sequence and use thereof
07/09/2013US8481296 Angiogenic tyrosyl t-RNA synthetase compositions and methods
07/09/2013US8481290 Antibody specific for a chondroitin sulphate epitope
07/09/2013US8481289 Triple acting antimicrobials that are refractory to resistance development
07/09/2013US8481286 Method for production of isoprenoid compounds
07/09/2013US8481284 Process of preparing conjugates of allium organosulfur compounds with amino acids, peptides, and proteins
07/09/2013US8481039 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
07/09/2013US8481038 Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins
07/09/2013US8481035 Methods for treating chronic pelvic pain syndrome with antibodies that binds MCP-1 or MIP-1A
07/09/2013CA2598514C Mutant aox 1 promoters
07/09/2013CA2588221C Modified chimeric polypeptides with improved pharmacokinetic properties
07/09/2013CA2506127C Methods of generating high-production of antibodies from hybridomas created by in vitro immunization
07/09/2013CA2494216C Use of dendritic cells (dcs) expressing interleukin 12 (il-12)
07/09/2013CA2369413C Transmembrane protein expressed in prostate and other cancers
07/09/2013CA2354188C Cancer cell vaccine
07/09/2013CA2349468C Factor viii polypeptide having factor viii:c activity
07/04/2013WO2013098651A1 Methods and materials for reducing degradation of recombinant proteins
07/04/2013US20130172251 Modified ghrelin peptides
07/04/2013US20130171716 Animal product free system and process for purifying a botulinum toxin
07/04/2013US20130171693 Process for production of recombinant human growth hormone
07/04/2013US20130171692 Sugar-chain modified yeast and method for producing glycoprotein using the same
07/04/2013US20130171178 Immunogenic Peptides of Xage-1
07/04/2013US20130171157 NOGO Receptor-Mediated Blockade of Axonal Growth
07/04/2013US20130171138 Immunoglobulin Chimeric Monomer-Dimer Hybrids
07/03/2013EP2610350A1 Cell line, system and method for optical control of secondary messengers
07/03/2013EP2610349A1 Whole egg protein peptides, preparation method and use thereof
07/03/2013EP2610348A1 Novel artificial translation/synthesis system
07/03/2013EP2610338A1 Method for producing substance
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 1125